MEDITECH MODEL ABPM-04

K051149 · Meditech Kft. · DXN · Nov 18, 2005 · Cardiovascular

Device Facts

Record IDK051149
Device NameMEDITECH MODEL ABPM-04
ApplicantMeditech Kft.
Product CodeDXN · Cardiovascular
Decision DateNov 18, 2005
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.1130
Device ClassClass 2

Intended Use

The Meditech ABPM-04 device automatically measures the systolic and diastolic arterial blood pressure and the pulse rate of adult patients under ambulatory circumstances using the standard oscillometric method with a standard upper arm cuff, sequentially as preprogrammed by the adjoining software. The device is intended for use with the standard indications and contraindications for ambulatory blood pressure monitoring.

Device Story

Meditech ABPM-04 is an ambulatory blood pressure monitor; uses oscillometric method via standard upper arm cuff. Device automatically measures systolic/diastolic blood pressure and pulse rate based on preprogrammed intervals set by adjoining software. Used in clinical or ambulatory settings; operated by healthcare professionals or patients under physician guidance. Output data allows clinicians to assess blood pressure trends over time, aiding in hypertension diagnosis and management. Benefits include continuous monitoring outside clinical environment, providing comprehensive blood pressure profile.

Clinical Evidence

No clinical data provided; substantial equivalence based on technological characteristics and intended use.

Technological Characteristics

Noninvasive oscillometric blood pressure monitor; uses standard upper arm cuff; microprocessor-controlled; software-driven measurement intervals; Class II device.

Indications for Use

Indicated for adult patients requiring ambulatory blood pressure monitoring to measure systolic/diastolic arterial blood pressure and pulse rate.

Regulatory Classification

Identification

A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features a stylized eagle with its wings spread, facing to the right. The eagle is surrounded by a circular border containing the text "U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. USA" in capital letters. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 NOV 1 8 2005 MEDITECH KFT. c/o Mr. Benny Arazy Arazy Group Mizpe Aviv, Industrial Park 13 M. P. Misgav 20187 ISRAEL Re: K051149 Trade Name: Meditech ABPM-04 Ambulatory Blood Pressure Monitor Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Measurement System Regulatory Class: Class II (two) Product Code: DXN Dated: May 4, 2005 Received: May 4, 2005 Dear Mr. Arazy: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Page 2 -- Mr. Benny Arazy Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Blimimton for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## 8.3 Indications for Use ## 510(k) Number (if known): Not applicable Device Name: Noninvasive Blood Pressure Measurement System, Meditech ABPM-04 ## Indications for Use: The Meditech ABPM-04 device automatically measures the systolic and diastolic arterial blood pressure and the pulse rate of adult patients under ambulatory circumstances using the standard oscillometric method with a standard upper arm cuff, sequentially as preprogrammed by the adjoining software. The device is intended for use with the standard indications and contraindications for ambulatory blood pressure monitoring. Image /page/2/Picture/5 description: The image shows a logo with the word "Modtech" in a stylized font at the top left. To the right of the word is a grid of nine circles, with eight of them filled in black and one in the bottom right corner left white. The logo appears to be for a technology-related company or product. Meditech Kit, - Orvosi F 1191 Budapest, Ulloi ut . Adoszára: 10397880- Prescription Use ・・・ AND / OR Over-the-Counter Use (21 CFR 801 Subpart C) (Part 21 CFR 801 Subpart D) Srilanka General Manager (Name & Signature) 4-12-05 **Date** (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Brammer Page 1 of 1 on sign-om Islon of Cardiovascular Devic 510(k) Number 15/140 40 / 40
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%